Rumi Mifuji‐Moroka

598 total citations
20 papers, 439 citations indexed

About

Rumi Mifuji‐Moroka is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Rumi Mifuji‐Moroka has authored 20 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Rumi Mifuji‐Moroka's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (6 papers) and Alcohol Consumption and Health Effects (3 papers). Rumi Mifuji‐Moroka is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (6 papers) and Alcohol Consumption and Health Effects (3 papers). Rumi Mifuji‐Moroka collaborates with scholars based in Japan and United States. Rumi Mifuji‐Moroka's co-authors include Motoh Iwasa, Yoshiyuki Takei, Yoshinao Kobayashi, Ryosuke Sugimoto, Nagisa Hara, Kazuko Iwata, Naoki Fujita, Esteban C. Gabazza, Hiroshi Hasegawa and Hideaki Tanaka and has published in prestigious journals such as PLoS ONE, Diabetes and Atherosclerosis.

In The Last Decade

Rumi Mifuji‐Moroka

20 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rumi Mifuji‐Moroka Japan 13 202 184 142 110 52 20 439
Sabrina Alves Fernandes Brazil 13 232 1.1× 302 1.6× 210 1.5× 78 0.7× 61 1.2× 42 566
M. Siciliano Italy 8 187 0.9× 256 1.4× 343 2.4× 70 0.6× 168 3.2× 13 584
Eleni Tsiaousi Greece 4 130 0.6× 295 1.6× 126 0.9× 51 0.5× 48 0.9× 5 370
I. Bilbao Spain 7 123 0.6× 190 1.0× 99 0.7× 56 0.5× 101 1.9× 13 425
Johannie du Plessis Belgium 7 108 0.5× 416 2.3× 188 1.3× 96 0.9× 102 2.0× 8 545
Miren Bravo Spain 9 62 0.3× 203 1.1× 115 0.8× 108 1.0× 104 2.0× 14 453
Ryujin Endo Japan 15 55 0.3× 306 1.7× 363 2.6× 63 0.6× 110 2.1× 28 592
Maurycy Jonas Poland 10 132 0.7× 134 0.7× 33 0.2× 78 0.7× 52 1.0× 23 386
Keisuke Osakabe Japan 12 45 0.2× 418 2.3× 221 1.6× 229 2.1× 57 1.1× 31 719
Clémence M. Canivet France 14 82 0.4× 401 2.2× 190 1.3× 84 0.8× 89 1.7× 37 553

Countries citing papers authored by Rumi Mifuji‐Moroka

Since Specialization
Citations

This map shows the geographic impact of Rumi Mifuji‐Moroka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rumi Mifuji‐Moroka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rumi Mifuji‐Moroka more than expected).

Fields of papers citing papers by Rumi Mifuji‐Moroka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rumi Mifuji‐Moroka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rumi Mifuji‐Moroka. The network helps show where Rumi Mifuji‐Moroka may publish in the future.

Co-authorship network of co-authors of Rumi Mifuji‐Moroka

This figure shows the co-authorship network connecting the top 25 collaborators of Rumi Mifuji‐Moroka. A scholar is included among the top collaborators of Rumi Mifuji‐Moroka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rumi Mifuji‐Moroka. Rumi Mifuji‐Moroka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishihama, Kota, Taro Yasuma, Yutaka Yano, et al.. (2018). Anti-apoptotic activity of human matrix metalloproteinase-2 attenuates diabetes mellitus. Metabolism. 82. 88–99. 16 indexed citations
2.
Toda, Masaaki, Taro Yasuma, Rumi Mifuji‐Moroka, et al.. (2017). Low dose of alcohol attenuates pro-atherosclerotic activity of thrombin. Atherosclerosis. 265. 215–224. 8 indexed citations
3.
Kobayashi, Yoshinao, Nagisa Hara, Ryosuke Sugimoto, et al.. (2017). The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD). Internal Medicine. 56(7). 755–762. 32 indexed citations
4.
Iwasa, Motoh, Ryosuke Sugimoto, Nagisa Hara, Rumi Mifuji‐Moroka, & Yoshiyuki Takei. (2016). <b>Hyponatremia Observed in Hepatic Cirrhosis is Associated with Renal Function, Use of Diuretics and Survival</b>. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 47(1). 21–24. 2 indexed citations
5.
Iwasa, Motoh, Ryosuke Sugimoto, Rumi Mifuji‐Moroka, et al.. (2016). Factors contributing to the development of overt encephalopathy in liver cirrhosis patients. Metabolic Brain Disease. 31(5). 1151–1156. 19 indexed citations
6.
Yasuma, Taro, Yutaka Yano, Corina N. D’Alessandro‐Gabazza, et al.. (2016). Amelioration of Diabetes by Protein S. Diabetes. 65(7). 1940–1951. 24 indexed citations
7.
Hara, Nagisa, Motoh Iwasa, Ryosuke Sugimoto, et al.. (2016). Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis. Internal Medicine. 55(8). 863–870. 87 indexed citations
8.
Iwasa, Motoh, Tomoaki Ishihara, Rumi Mifuji‐Moroka, et al.. (2015). Elevation of branched-chain amino acid levels in diabetes and NAFL and changes with antidiabetic drug treatment. Obesity Research & Clinical Practice. 9(3). 293–297. 37 indexed citations
9.
Iwasa, Motoh, Ryosuke Sugimoto, Kyoko Yoshikawa, et al.. (2015). Change in skeletal muscle mass after administering entecavir in patients with hepatitis B. Nutrition. 31(9). 1173–1174. 7 indexed citations
10.
Iwasa, Motoh, Ryosuke Sugimoto, Tomoaki Ishihara, et al.. (2015). Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma. Journal of Nutritional Science and Vitaminology. 61(6). 433–440. 13 indexed citations
11.
Mifuji‐Moroka, Rumi, Corina N. D’Alessandro‐Gabazza, Masaaki Toda, et al.. (2014). Protein S exacerbates alcoholic hepatitis by stimulating liver natural killer T cells. Journal of Thrombosis and Haemostasis. 13(1). 142–154. 14 indexed citations
12.
Iwasa, Motoh, Kazuko Iwata, Nagisa Hara, et al.. (2013). Nutrition therapy using a multidisciplinary team improves survival rates in patients with liver cirrhosis. Nutrition. 29(11-12). 1418–1421. 62 indexed citations
13.
Iwasa, Motoh, Yoshinao Kobayashi, Rumi Mifuji‐Moroka, et al.. (2013). Branched-Chain Amino Acid Supplementation Reduces Oxidative Stress and Prolongs Survival in Rats with Advanced Liver Cirrhosis. PLoS ONE. 8(7). e70309–e70309. 57 indexed citations
14.
Mifuji‐Moroka, Rumi, Motoh Iwasa, Ryosuke Sugimoto, et al.. (2013). Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetes.. PubMed. 60(127). 1736–41. 2 indexed citations
15.
Kobayashi, Yoshinao, Motoh Iwasa, Ryosuke Sugimoto, et al.. (2013). Hepatobiliary and Pancreatic: Duodenal bleeding from a hepatic artery aneurysm. Journal of Gastroenterology and Hepatology. 28(8). 1256–1256. 1 indexed citations
16.
Kobayashi, Yoshinao, Motoh Iwasa, Ryosuke Sugimoto, et al.. (2013). Effect of Iron-Mediated Oxidative Stress on Insulin Resistance Through the Forkhead Box-Containing Protein O Subfamily-1 (FOXO-1) Pathway in Chronic Hepatitis C. International Journal of Clinical Medicine. 4(1). 10–18. 2 indexed citations
17.
Iwasa, Motoh, Rumi Mifuji‐Moroka, Makoto Kuroda, et al.. (2012). Regional reduction in gray and white matter volume in brains of cirrhotic patients: voxel-based analysis of MRI. Metabolic Brain Disease. 27(4). 551–557. 26 indexed citations
18.
Mifuji‐Moroka, Rumi, Motoh Iwasa, R. Sugimoto, et al.. (2012). Hepatobiliary and Pancreatic: Liver abscess associated with lipoma of duodenum. Journal of Gastroenterology and Hepatology. 27(6). 1129–1129. 1 indexed citations
19.
Iwasa, Motoh, Rumi Mifuji‐Moroka, Nagisa Hara, et al.. (2011). Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C. Diabetes Research and Clinical Practice. 94(3). 468–470. 12 indexed citations
20.
Gil-Bernabe, Paloma, Corina N. D’Alessandro‐Gabazza, Masaaki Toda, et al.. (2011). Atherosclerosis Amelioration by Moderate Alcohol Consumption Is Associated With Increased Circulating Levels of Stromal Cell-Derived Factor-1. Circulation Journal. 75(9). 2269–2279. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabrina Alves Fernandes Breakdown of academic impact, for papers by M. Siciliano Breakdown of academic impact, for papers by Eleni Tsiaousi Breakdown of academic impact, for papers by I. Bilbao Breakdown of academic impact, for papers by Johannie du Plessis Breakdown of academic impact, for papers by Miren Bravo Breakdown of academic impact, for papers by Ryujin Endo Breakdown of academic impact, for papers by Maurycy Jonas Breakdown of academic impact, for papers by Keisuke Osakabe Breakdown of academic impact, for papers by Clémence M. Canivet
Rankless by CCL
2026